Moderna Says CHMP Recommends Marketing Authorization For MRESVIA RSV Vaccine In EU

Moderna, Inc. (MRNA) announced Friday that the European Medicines Agency\'s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of marketing authorization in the European Union for mRESVIA (mRNA-1345) to protect adults aged 60 years and older from lower respiratory tract disease caused by RSV infection. Following...

Read More

The Bitcoin Black Hole Effect:Our savings accounts can be thought of as the sum value of the energy output of our life’s work

Inflation is a hidden tax on the common people and is something you need to understand and be positioned accordingly as both an investor/citizen moving into the near future.Imagine the value of your life’s work cutting in half every 15 hours,at no fault of your own,this is what happened during the worst case of hyperinflation...

Read More

Aerovate Says Phase 2b Portion Of Trial Of AV-101 Fails To Meet Primary And Secondary Endpoints

Biopharmaceutical company Aerovate Therapeutics, Inc. (AVTE) announced Monday topline results from the Phase 2b portion of the Inhaled iMatinib Pulmonary Arterial Hypertension Clinical Trial (IMPAHCT), a Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multi-national trial of AV-101. AV-101 is a novel dry powder inhaled formulation of imatinib, in adults with pulmonary arterial hypertension (PAH). The objective...

Read More

New Zealand Trade Data Due On Tuesday

New Zealand will on Tuesday release September figures for imports, exports and trade balance, highlighting a light day for Asia-Pacific economic activity. South Korea will see September numbers for producer prices; in August, producer prices were down 0.1 percent on month and up 1.6 percent on year. Hong Kong will provide September data for consumer...

Read More